{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-07",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "42816-1108",
      "generic_name": "CONJUGATED ESTROGENS and MEDROXYPROGESTERONE ACETATE",
      "labeler_name": "Pfizer Ireland Pharmaceuticals Unlimited Company",
      "active_ingredients": [
        {
          "name": "ESTROGENS, CONJUGATED",
          "strength": ".625 mg/1"
        },
        {
          "name": "MEDROXYPROGESTERONE ACETATE",
          "strength": "5 mg/1"
        }
      ],
      "finished": false,
      "packaging": [
        {
          "package_ndc": "42816-1108-1",
          "description": "1 BAG in 1 BOX (42816-1108-1)  / 69125 TABLET, SUGAR COATED in 1 BAG",
          "marketing_start_date": "01-JAN-12"
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {},
      "marketing_category": "DRUG FOR FURTHER PROCESSING",
      "dosage_form": "TABLET, SUGAR COATED",
      "spl_id": "5dfe937b-3c15-4861-b252-620a1688c36a",
      "product_type": "DRUG FOR FURTHER PROCESSING",
      "marketing_start_date": "20120101",
      "product_id": "42816-1108_5dfe937b-3c15-4861-b252-620a1688c36a",
      "brand_name_base": null
    }
  ]
}